Dr. Jayaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
239 Station St
Jacksonville, NC 28546Phone+1 910-353-0819Fax+1 910-353-0828
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011- Indiana University School of MedicineInternship, Internal Medicine, 2005 - 2008
- Indiana University School of Medicine2008
St. George's University School of MedicineClass of 2005
Butler University College of PharmacyBS, Science, 1995 - 1998
Indiana UniversityBS, Microbiology, 1993 - 1995
Certifications & Licensure
IN State Medical License 1998 - 2026
NC State Medical License 2011 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Winner ASCO 2010 Merit Award 2010
- Winner Best Chairman’s Rounds presentation 2008
- Winner State ACP Abstract competition 2005 Indiana Chapter ACP meeting, 2005
Publications & Presentations
PubMed
- 23 citationsA randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated exten...Rachel E. Sanborn, Jyoti D. Patel, Gregory A. Masters, Nagesh Jayaram, Anthony W. Stephens
Cancer. 2017-01-15 - 47 citationsDirect Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.Deborah Schrag, Hajime Uno, Rachel Rosovsky, Cynthia Rutherford, Kristen Sanfilippo
JAMA. 2023-06-13 - 13 citationsNicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin.Praveen Kusumanchi, Yonghua Zhang, M B Jani, N H Jayaram, R A Khan
Cancer Gene Therapy. 2013-07-01
Journal Articles
- Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.Hiremagalur N. Jayaram, Kamran Gharehbaghi, Nagesh H. Jayaram, Jason Rieser, Karsten Krohn, Kenneth D. Paull, Biochemical and Biophysical Research Communication 186
- Testicular Cancer.Loehrer, Patrick J., Jayaram, Nagesh, Dash, Atreya, Buyyounowski, Mark K., Sharecky, Douglass, Cancer Management: A Multidisciplinary Approach
- Pro-Drug Targeted Gene Therapy for Colorectal Cancer.Kusumanchi P, Zhang Y, Jayaram N, Antony Asok, Jayaram H, Brit J Cancer
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
